Medical Science Liaison (Central Atlantic)

ADC Therapeutics•Charlotte, NC

4d•Remote

About The Position

At ADC Therapeutics, we are passionate about revolutionizing cancer treatment. When you join our team, you become part of a mission-driven group of talented individuals dedicated to making a difference in patients' lives. ADC Therapeutics (NYSE): is a commercial, global leader and pioneer in the field of antibody-drug conjugates (ADCs) with specialized capabilities from clinical through commercialization. Our CD-19-directed ADC for relapsed/refractory non-Hodgkin lymphoma, ZYNLONTA® (loncastuxamab tesirine lpyl) has received accelerated approval in the United States and conditional approval from the European Commission. ZYNLONTA is also being evaluated in combination with other agents and in earlier lines of DLBCL therapy as well as in indolent lymphomas including follicular lymphoma and marginal zone lymphoma with the potential to reach significantly more patients through expanded use. We are a team of approximately 150 patient-focused, purpose-driven employees with a shared mission to transform the treatment paradigm for patients. If you’re interested in making a difference in the lives of patients worldwide with a team of like-minded colleagues, operating in a flexible work environment, come join us on our journey! The MSL is responsible for liaising with a variety of internal and external customers and providing medical and scientific information on the appropriate utilization of ADCT’s product. They will serve as experts in the therapeutic area and disease state area and support the marketed product and pipeline portfolio. This includes developing peer-level relationships with customers at the national, regional and local levels, researchers, population-based decision makers in the payer community consistent with Medical Affairs objectives. This field-based position will collect field insights to inform medical affairs objectives. Job level (MSL, Sr., A.D.) will be commensurate with experience and education. The position will report to the Head of Field Medical Affairs and Medical Communications. Territory for this geography includes OH, KY, TN, VA, NC

Requirements

Bachelor’s degree required.
MSL experience required.
Knowledge of the PhRMA, OIG and other relevant guidelines.
Good understanding of the clinical development process and the ICH-GCP guidelines.
Customer-oriented – ability to meet/exceed customers’ needs.
Excellent communication skills – verbal and written.
Leadership – ethical, focused, organized.
Field-based role – must be located within the pre-specified regional territory.

Nice To Haves

Advanced degree in life sciences (MD, PharmD or PhD) preferred.
Previous experience of working within hematology oncology preferred.
Proven ability to create and sustain relationships with industry leaders.
Demonstrated ability to organize, prioritize and work effectively with minimal supervision in a constantly changing environment.

Responsibilities

Provide healthcare professionals (HCPs) credible, balanced, scientific information about ADCT and its product, pipeline, research activities, and ADCT product development.
Respond to unsolicited medical information requests in the field.
Develop territory plans to initiate and maintain strong relationships with Key Opinion Leaders (KOLs) and Health Care Providers (HCPs).
Maintain medical expertise and a strong understanding of hematology/oncology clinical practice.
Cover sessions and collect insights at scientific congresses.
Develop and demonstrate competencies in the understanding and communication of relevant scientific information, including but not limited to disease state, therapeutic landscape, clinical data, mechanism of action for therapeutics agents, RWE.
Maintain the highest ethical and professional standards and in accordance with the relevant guidelines.
Collaborate with key functional leaders and project team members, building collegiate, compliant and successful teams.
Ensure alignment across functions by working in partnership with key stakeholders.